文献速递关节外科

OBTAIN A:氨甲环酸在全髋关节置换术中的结局获益——一项随机双盲对照试验

OBTAIN A: Outcome Benefits of Tranexamic Acid in Hip Arthroplasty. A Randomized Double-Blinded Controlled Trial.
PubMed 文献 · J Arthroplasty · 2016-12-08

单中心随机双盲安慰剂对照试验纳入101例直接前入路全髋关节置换术患者,比较氨甲环酸与等量生理盐水;氨甲环酸组术中失血量和估计失血量均显著少于对照组,住院时间显著缩短,但大腿肿胀、疼痛和活动能力无统计学显著差异。

要点

  • 氨甲环酸组术中失血量0.460L(SD 0.228) vs 对照组0.687L(SD 0.283),氨甲环酸组显著减少。
  • 氨甲环酸组住院时间3.58天(SD 0.84) vs 对照组4.27天(SD 0.98),氨甲环酸组显著缩短(P<.001)。
  • 大腿肿胀、疼痛和活动能力等主要及次要结局两组间无统计学显著差异。

核心结论

  • 氨甲环酸是减少直接前入路全髋关节置换术失血的有效药物,但其血液保护效应未伴随疼痛和活动能力等术后恢复指标的改善,氨甲环酸给药可能对缩短住院时间有正面作用。

研究设计与样本

  • 单中心、随机、双盲、安慰剂对照试验,101例患者随机接受氨甲环酸或等量生理盐水。
  • 主要结局指标为大腿肿胀,次要结局包括视觉模拟疼痛评分、计时起立-行走测试、10米步行测试和住院时间,同时记录失血量和输血发生率。

主要发现

  • 主要结局大腿肿胀及次要结局术后疼痛和活动能力两组间无统计学显著差异。
  • 氨甲环酸组住院时间3.58天(SD 0.84) vs 对照组4.27天(SD 0.98),氨甲环酸组显著缩短(P<.001)。
  • 氨甲环酸组术中失血量0.460L(SD 0.228) vs 对照组0.687L(SD 0.283),氨甲环酸组显著减少(P<.001)。
  • 氨甲环酸组估计失血量1.084L(SD 0.440) vs 对照组1.394L(SD 0.426),氨甲环酸组显著减少。

关键数值与推荐

  • 氨甲环酸组住院时间3.58天(SD 0.84) vs 对照组4.27天(SD 0.98),P<.001。
  • 氨甲环酸组术中失血量0.460L(SD 0.228) vs 对照组0.687L(SD 0.283),P<.001。
  • 氨甲环酸组估计失血量1.084L(SD 0.440) vs 对照组1.394L(SD 0.426)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We examined whether the blood conserving effect of tranexamic acid (TXA) in total hip arthroplasty using the direct anterior approach, translates to an effect on functional outcomes in the perioperative period. METHODS: We conducted a single-center, randomized, double-blinded, placebo-controlled trial. One hundred one patients were randomized to receive either TXA or an equivalent volume of normal saline. The primary outcome measure was thigh swelling. Secondary outcome measures included, visual analogue pain score, timed up and go test, a 10 meter walk test, and length of stay. Blood loss and the incidence of blood transfusions were also recorded. RESULTS: There were no statistically significant differences between the primary outcome of thigh swelling or the secondary outcome measures of postoperative pain nor mobility. There was a significant reduction in length of stay for those that received TXA 3.58 days (0.84) compared with the control group 4.27 days (0.98) (P < .001). There was significantly less intraoperative blood loss observed in the TXA group (0.460L SD 0.228) compared with the control group (0.687L SD 0.283L) (P < .001). The estimated blood loss was also significantly less in the TXA group (1.084L SD 0.440) compared with the control group (1.394 L SD 0.426). CONCLUSION: TXA is an effective agent in reducing blood loss in total hip arthroplasty using the anterior approach. The blood conserving effect of TXA was not associated with improved postoperative recovery across the measures of pain and mobility. Administration of TXA may have a positive effect on reducing the duration of inpatient stays.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fraval A, Effeney P, Fiddelaers L, et al. OBTAIN A: Outcome Benefits of Tranexamic Acid in Hip Arthroplasty. A Randomized Double-Blinded Controlled Trial. J Arthroplasty. 2016. PMID: 28089468. doi:10.1016/j.arth.2016.11.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。